Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals
Lundbeck signs $2.5B check for Longboard, seeing blockbuster potential in epilepsy med
As election day nears, Trump and Harris veer in different directions on pharma
GSK asthma hope depemokimab works in second indication
*please scroll down for all the latest news*
